Milestone Scientific Inc.
MLSSAMEXHealthcare● Active
$0.38
$-0.00(-0.55%)
Market Cap$33715187
P/E Ratio—
52W High$0.92
52W Low$0.22
Milestone Scientific Inc. (MLSS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MLSS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.01
Est. -$0.01 · +33.3%
Revenue
$0.00B
Est. $0.00B · -4.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
MLSS reports quarterly as a AMEX-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.01 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 13, 2026 | -$0.01 | -$0.01 | +33.3% | $0.00B | $0.00B | -4.0% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -$0.01 | -$0.02 | -33.3% | $0.00B | $0.00B | -10.6% |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$0.01 | -$0.01 | +33.3% | $0.00B | $0.00B | +2.2% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.01 | -$0.02 | -100.0% | $0.00B | $0.00B | +1.0% |
| ▼ Q2 FY2025 | Apr 15, 2025 | -$0.01 | -$0.03 | -200.0% | $0.00B | $0.00B | -10.7% |
| ▼ Q1 FY2025 | Mar 28, 2025 | -$0.01 | -$0.03 | -155.1% | $0.00B | $0.00B | -24.1% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.01 | -$0.02 | -100.0% | $0.00B | $0.00B | -5.3% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+33.3%
Revenue
$0.00B
Q1 FY2026
Mar 31, 2026Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-33.3%
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+33.3%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-100.0%
Revenue
$0.00B
Q2 FY2025
Apr 15, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.01
EPS Surpr.
-200.0%
Revenue
$0.00B
Q1 FY2025
Mar 28, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.01
EPS Surpr.
-155.1%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-100.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +33.3% | $0.35 | $0.35 | +0.09% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -33.3% | $0.30 | $0.29 | -5.26% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +33.3% | $0.36 | $0.38 | +6.03% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -100.0% | $0.60 | $0.58 | -3.77% |
| ▼ Q2 FY2025 | Apr 15, 2025 | -200.0% | $0.91 | $0.96 | +4.63% |
| ▼ Q1 FY2025 | Mar 28, 2025 | -155.1% | $1.08 | $0.99 | -8.33% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -100.0% | $0.67 | $0.68 | +1.39% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -100.0% | $1.02 | $1.01 | -0.98% |
Q2 FY2026+0.09%
Report Date
May 13, 2026
EPS Beat/Miss
+33.3%
Price Before
$0.35
Price After
$0.35
Q1 FY2026-5.26%
Report Date
Mar 31, 2026
EPS Beat/Miss
-33.3%
Price Before
$0.30
Price After
$0.29
Q4 FY2025+6.03%
Report Date
Nov 13, 2025
EPS Beat/Miss
+33.3%
Price Before
$0.36
Price After
$0.38
Q3 FY2025-3.77%
Report Date
Aug 14, 2025
EPS Beat/Miss
-100.0%
Price Before
$0.60
Price After
$0.58
Q2 FY2025+4.63%
Report Date
Apr 15, 2025
EPS Beat/Miss
-200.0%
Price Before
$0.91
Price After
$0.96
Q1 FY2025-8.33%
Report Date
Mar 28, 2025
EPS Beat/Miss
-155.1%
Price Before
$1.08
Price After
$0.99
Q4 FY2024+1.39%
Report Date
Nov 14, 2024
EPS Beat/Miss
-100.0%
Price Before
$0.67
Price After
$0.68
Q3 FY2024-0.98%
Report Date
Aug 14, 2024
EPS Beat/Miss
-100.0%
Price Before
$1.02
Price After
$1.01
Avg Beat Reaction+3.06%
Avg Miss Reaction-2.05%
Beat Rate2 / 8 quarters
Largest Move-8.33% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MLSS ends December
Milestone Scientific Inc. (MLSS) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.01 — beating the analyst consensus of $-0.01 by +33.3%. The next MLSS earnings date is expected around September 1, 2026.
Each quarter, investors track MLSS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MLSS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MLSS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MLSS earnings · 5 questionsMilestone Scientific Inc.'s next earnings report is expected around September 1, 2026. MLSS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MLSS historically reports after market close (AMC).
MLSS earnings datewhen is MLSS earningsMLSS next earnings datewhen does MLSS report earningsMLSS earnings calendar
▸ Source: FMP · Milestone Scientific Inc. SEC filings · US GAAP · Milestone Scientific Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026